Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ritter

Showing results (151-160 of 153) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 153 results.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 1, 1992
Guidelines for transesophageal echocardiography in childrenD A Fyfe, S B Ritter, A R Snider, et al.
Journal of the American College of Radiology : JACR|February 28, 2026
ACR Appropriateness Criteria® Demyelinating Diseases, Aleks Kalnins, Lenora M Lewis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2018
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patientsC Röllig, M Kramer, M Gabrecht, et al.
Pageof 16

Showing results (151-160 of 153) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 153 results.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 1, 1992
Guidelines for transesophageal echocardiography in childrenD A Fyfe, S B Ritter, A R Snider, et al.
Journal of the American College of Radiology : JACR|February 28, 2026
ACR Appropriateness Criteria® Demyelinating Diseases, Aleks Kalnins, Lenora M Lewis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2018
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patientsC Röllig, M Kramer, M Gabrecht, et al.
Pageof 16